Replies to post #32001 on Ariad Pharmaceuticals Inc fka ARIA

[Whosetosay]

jb, I trust you are correct, though I think the annual price is even less. No doubt EPIC will supercharge EU revs.

Positive 2014 eps may hinge on the next molecule.

I'm hoping we try to eek by without another shelf, maybe get a loan, but I see another 10M offering next year. If we announce another molecule, probably make that 20M.